<?xml version='1.0' encoding='UTF-8'?>
<rss version="2.0">
  <channel>
    <title>Rejected PubMed Papers – Not Head and Neck Cancer</title>
    <link>https://pubmed.ncbi.nlm.nih.gov/rss/search/1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ/?limit=100</link>
    <description>Papers rejected by the automated classifier</description>
    <lastBuildDate>Mon, 22 Dec 2025 22:45:30 +0000</lastBuildDate>
    <item>
      <title>Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41427952/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41427952</guid>
      <description>CONCLUSION: The study was terminated early with a small sample size, limiting interpretation, although antitumor activity was limited. Future studies of capivasertib in hematologic malignancies would likely require biomarker-directed patient selection and/or combination therapy.</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Identifying Risk Factors for Sialolithiasis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41424261/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41424261</guid>
      <description>CONCLUSIONS: This study, using a large-scale database, aimed to identify potential risk factors associated with sialolithiasis, thereby improving our understanding of its pathogenesis and paving the way for early diagnosis and intervention. The commonality among the identified risk factors appears to be their association with reduced salivary flow or alterations in fluid dynamics and composition, which are known contributors to the formation of salivary stones.</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Placental-Derived Connective Tissue Matrix Mediates Murine Recurrent Laryngeal Nerve Regeneration</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41424184/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41424184</guid>
      <description>CONCLUSION: pd-CTM may be a novel treatment option for patients with UVFP based on the neurotrophic, angiogenic, tissue remodeling, and anti-inflammatory factors present.</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>A Phase I study targeting the APE1/ref-1 redox signaling protein with APX3330: First clinical agent targeting APE1/ref-1 in Cancer</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41423797/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41423797</guid>
      <description>CONCLUSIONS: APX3330 showed preliminary signals of disease control and on-target pharmacology in this first-in-human study. Based on safety and PD, the RP2D is 600 mg/day. Given the small sample size, efficacy conclusions are exploratory (ClinicalTrials.gov Identifier: NCT03375086).</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Antibiotic use and survival from breast cancer: A population-based cohort study in England and Wales</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41423616/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41423616</guid>
      <description>The role of the gut microbiota in carcinogenesis is increasingly being acknowledged. Recent studies in multiple breast cancer mouse models have found that antibiotics, by altering the gut microbiota, can accelerate tumour growth. In humans, a recent cohort study restricted to triple negative breast cancer showed that breast cancer patients using a greater number of antibiotics had markedly worse survival. These studies have raised concerns about repeated antibiotic use in breast cancer patients....</description>
      <pubDate>Sun, 21 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Effects of mitotically active polyploid giant cancer cells on chemoresistance through interaction with cancer-associated fibroblasts</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41423506/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41423506</guid>
      <description>CONCLUSIONS: Our findings identify MA-PGCCs as a proliferative subpopulation that promotes EMT and chemoresistance through a TGF-β-uPA/uPAR feedback loop. Targeting this pathway may offer a novel therapeutic strategy for the treatment of aggressive tumors enriched in MA-PGCCs.</description>
      <pubDate>Sun, 21 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41423505/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41423505</guid>
      <description>CONCLUSION: Vitamin D supplementation did not prevent PC progression, although reduced prevalence of CBMN markers may indicate a benefit of vitamin D supplementation.</description>
      <pubDate>Sun, 21 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Oral small-molecule GLP-1 receptor agonist for type 2 diabetes and obesity</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41421831/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41421831</guid>
      <description>No abstract</description>
      <pubDate>Sat, 20 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Distinct Tumor-Immune Ecologies in Lung Cancer Patients Predict Progression and Define a Clinical Biomarker of Therapy Response</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41418101/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41418101</guid>
      <description>Multiplexed imaging of tissues is an approach that holds promise for improving early detection, diagnosis, and treatment of cancer. Here, we investigated multiplexed histological images of paired pre- and on-treatment samples from nine patients with immunotherapy-refractory non-small cell lung cancer (NSCLC) treated with an oral HDAC inhibitor (vorinostat) combined with a PD-1 inhibitor (pembrolizumab). Patient responses comprised of either stable disease (SD) or progressive disease (PD). An...</description>
      <pubDate>Fri, 19 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Maxillary Sinus Papillary Edema as a Predictor of Odontogenic Sinusitis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41416639/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41416639</guid>
      <description>CONCLUSIONS: MSPE is a distinct finding that is reliably identifiable and is significantly more likely in ODS compared to infectious CRSsNP and noninfectious CRSwNP. With 100% sensitivity and NPV, MSPE absence makes ODS very unlikely. With 86% PPV, MSPE is not pathognomonic for ODS, but should arouse suspicion for a possible odontogenic source.</description>
      <pubDate>Fri, 19 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Molecular mechanisms of receptor recognition and antibody neutralization of coxsackievirus A6</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41413343/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41413343</guid>
      <description>Coxsackievirus A6 (CVA6), a major cause of hand, foot, and mouth disease, lacks approved vaccines or drugs. KRM1 is its only known receptor, but its precise role remains unclear. This study investigates CVA6's entry mechanism and antibody neutralization. Cryo-EM shows CVA6 clinical strain HeB primarily exists as mature virions. KRM1 binding within the canyon triggers conversion to uncoating intermediate, defining KRM1 as an uncoating receptor for CVA6. However, KRM1 knockout reduces CVA6...</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Gut microbiota modulates aversive learning and memory of honeybees (Apis mellifera)</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41413037/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41413037</guid>
      <description>Growing evidence indicates that host behaviors are regulated by the gut-brain interaction. In honeybees (Apis mellifera), a critical defensive behavior is the sting extension reflex. However, it remains unclear how the gut microbiota affects aversive learning and memory of this behavior. Here we demonstrate that the normal gut microbiota contributes to aversive learning and memory of the sting extension reflex in honeybees. Metabolomics analysis reveals that the gut microbiota affects tyrosine...</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Manganese-engineered Lactobacillus Reuteri with enhanced antitumor and immunomodulatory activities for colorectal cancer prevention and treatment</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41413024/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41413024</guid>
      <description>Probiotic-based biotherapy for colorectal cancer (CRC) faces significant challenges due to poor tumor-targeting and limited bioactivities within the complex tumor microenvironment. This study shows that Lactobacillus reuteri (L. reuteri)'s inherent bioactivities, including proliferation, metabolism, and colorectal colonization, can be enhanced by manganese, prompting the fabrication of a manganese-engineered strain (MnLR). Oral administration of MnLR with its metabolic substrate-glycerol...</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trial</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41412437/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41412437</guid>
      <description>CONCLUSIONS: SIB-RT combined with oral S-1 chemotherapy significantly improved long-term survival and therefore might be considered a standard of care for elderly patients with inoperable ESCC. TRIAL REGISTRATION Clinical Trials.gov Identifier: NCT0297969.</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Giredestrant Delivers Long-Sought Adjuvant Benefit</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41410646/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41410646</guid>
      <description>The oral selective estrogen receptor degrader giredestrant prolonged invasive disease-free survival more than standard endocrine therapies, such as tamoxifen, letrozole, anastrozole, and exemestane, in the phase III lidERA study. Despite the lack of comparisons between the drug and CDK4/6 inhibitors and concerns over its potential cost, researchers were excited by the data, noting that it's the first improvement in adjuvant endocrine therapy in two decades.</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Patterns of Clinical Presentations for Voice Care Among Professional and Student Singers</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41410286/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41410286</guid>
      <description>CONCLUSION: These data inform counseling for professional singers and support screening exams at early career milestones to reduce healthcare burden and costs over the lifetime for this high-risk population.</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41406445/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41406445</guid>
      <description>CONCLUSIONS: Among persons with tuberculous meningitis, no evidence of beneficial effect from high-dose rifampin was observed, and the potential for a harmful effect cannot be ruled out. (Funded by the U.K. Medical Research Council and others; ISRCTN Registry number, ISRCTN15668391.).</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>The Lived Experience of Facial Paralysis: Impact of Etiology on Patient Perceptions</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41405162/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41405162</guid>
      <description>CONCLUSION: Patient-reported outcomes and lived experience in facial paralysis differ meaningfully by etiology. Beyond clinical severity, a patient's emotional intelligence, social context, and underlying cause of paralysis shape personal perceptions of appearance, function, and well-being. These findings highlight the importance of etiology-specific counseling, rehabilitation, and psychosocial support to optimize recovery and quality of life.</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Oral TKI zongertinib gains accelerated approval for HER2-mutant NSCLC</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41405124/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41405124</guid>
      <description>No abstract</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Nationwide Survey on Recurrent Respiratory Papillomatosis in Japan: Analysis of Long-Term Patients</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41403135/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41403135</guid>
      <description>CONCLUSION: The present study revealed real-world data suggesting that the number of recent surgeries and Derkay's anatomical score may be associated with the clinical course of previously diagnosed RRP.</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Socioeconomic Inequalities in Oral Frailty and Its Components</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41403051/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41403051</guid>
      <description>CONCLUSIONS: Substantial socioeconomic inequalities in oral frailty were observed, with wealth being the most influential factor.</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Otorhinolaryngology-Themed Autonomous Sensory Meridian Response (ASMR) Videos on YouTube: Clinical Representation and Viewer Engagement</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41400180/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41400180</guid>
      <description>CONCLUSION: This first cross-sectional content analysis of otorhinolaryngology-themed ASMR videos reveals a dominance of otologic content with limited clinical accuracy or scope. The inverse association between CRS and viewer engagement suggests that the most popular videos may offer the least clinical realism. Although not educational in intent, their widespread reach raises important concerns about shaping public expectations of otolaryngologic care.</description>
      <pubDate>Tue, 16 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41398162/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41398162</guid>
      <description>Immune checkpoint inhibitors (ICIs) have improved survival in advanced non-small cell lung cancer (NSCLC), yet resistance remains a major challenge. Here, we report the results from cohort A of a multi-cohort, phase II, open-label trial [NCT04777084], evaluating the efficacy and safety of IBI318 (a bispecific anti-PD-1/PD-L1 antibody, 300 mg intravenous every 2 weeks) plus lenvatinib (a receptor tyrosine kinase inhibitor, 8 mg orally daily). Forty patients with advanced NSCLC and acquired...</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Saffold virus exploits integrin αvβ8 and sulfated glycosaminoglycans as cooperative attachment receptors for infection</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41397982/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41397982</guid>
      <description>Saffold virus (SAFV), a member of the species Cardiovirus saffoldi within the Picornaviridae family, causes acute respiratory and gastrointestinal illnesses as well as hand, foot, and mouth disease. It is also suspected to be associated with neuronal disorders, such as encephalitis and meningitis, in severe cases. Despite its clinical significance, the virus-host interactions underlying SAFV pathogenicity remain largely unknown. Using a genome-wide CRISPR-Cas9 knockout screen, we identify the...</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>The Maxillary Lid Approach to Intra-Antral Pathology</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41395765/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41395765</guid>
      <description>CONCLUSIONS: Re-apposition of a bony lid after a sublabial approach to the maxillary sinus could ameliorate historical drawbacks of the procedure, possibly expanding its application. Larger cohorts and long-term follow-up will further characterize ideal indications and potential pitfalls of the approach.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Health-Related Quality of Life in Patients Undergoing Surgery for Primary Hyperparathyroidism: Patient Reported Outcome Measures</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41392488/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174512&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41392488</guid>
      <description>CONCLUSION: Patients with PHPT demonstrated significant improvements in HRQL following surgery.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
  </channel>
</rss>
